CDKN2A and glioblastoma: Likewise, primary GBMs are characterized by EGFR overexpression, PTEN mutations, and CDKN2A (p16) deletions, while the most common and detectable alteration in secondary GBM, other than IDH1 gene mutations, is the presence of TP53 gene mutations [6].